A Study on the Effectiveness of Mass Screening for Cancer Using the Prefectural Cancer Registry
利用都道府县癌症登记处进行癌症大规模筛查的有效性研究
基本信息
- 批准号:10670355
- 负责人:
- 金额:$ 1.22万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Purpose: We conducted a survival analysis to assess the effectiveness of mass screening program for gastric, cervical, lung, intestinal, and breast cancers in Saga Prefectural using the data from the Saga Prefectural Cancer Registry.Methods: We utilized the data of the Saga Prefectural Cancer Registry from January, 1982 to December, 1996. We defined the screened group as patients whose cancer was first detected by the screening program, and assigned residual patients to the non-screened group. The number of cancer case in the screened and the non-screened group, were as follows, respectively: 1,451 and 8,325 of gastric cancer, 188 and 817 of cervical cancer, 544 and 3,778 of lung cancer, 210 and 4,537 of intestinal cancer, and 85 and 1,847 cases of breast cancer. We compared the 14-years cumulative survival rates of the screened group to those of the non-screened group by cancer site. Hazard ratios and their 95% confidence intervals for mortality regarding screening program were estimated with the Cox' proportional hazard model.Results: The screened group showed the significantly higher 14-years cumulative survival rates than the non-screened group regarding each screening program for gastric, cervical, lung, intestinal, and breast cancer. The risk in mortality was significantly decreased when cancer was detected by the screening program. The age and sex-adjusted hazard ratios (and their 95 % confidence intervals) for mortality of the screening program were 0.40 (0.36-0.44) for gastric cancer, 0.41 (0.27-0.62) for cervical cancer, 0.51 (0.45-0.57) for lung cancer, 0.45 (0.32-0.62) for intestinal cancer, and 0.43 (0.20-0.90) for breast cancer.Conclusion: Mass screening program for gastric, cervical, lung, intestinal, and breast cancer is thought to be effective in terms of 14-years cumulative survival rates according to the Saga Prefectural Cancer Registry.
目的:我们进行了生存分析,以评估胃癌,宫颈癌,肺癌,肠癌和乳腺癌在佐贺县使用的数据从佐贺县癌症Registry.Methods的大规模筛查计划的有效性:我们利用的数据从1982年1月至1996年12月的佐贺县癌症登记。我们将筛查组定义为通过筛查程序首次检测到癌症的患者,并将剩余患者分配到未筛查组。筛查组和未筛查组的癌症病例数分别为:胃癌1 451例和8 325例,宫颈癌188例和817例,肺癌544例和3 778例,肠癌210例和4 537例,乳腺癌85例和1 847例。我们通过癌症部位比较了筛查组与非筛查组的14年累积生存率。采用考克斯' proportional hazard model.Results:筛查组胃癌、宫颈癌、肺癌、肠癌、乳腺癌的14年累积生存率均显著高于非筛查组。当筛查项目检测到癌症时,死亡风险显著降低。年龄和性别调整的风险比筛查项目的死亡率(及其95%置信区间)为0.40(0.36-0.44)胃癌,0.41(0.27-0.62)宫颈癌,0.51(0.45-0.57)肺癌,0.45(0.32-0.62),0.43(0.20-0.90)。结论:根据佐贺县癌症登记处的数据,胃癌、宫颈癌、肺癌、肠癌和乳腺癌的大规模筛查计划被认为在14年累积生存率方面是有效的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MORI Mitsuru其他文献
MORI Mitsuru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MORI Mitsuru', 18)}}的其他基金
A case-control study on breast cancer with special reference to equol productivity and intestinal bacteria NATTS.
乳腺癌病例对照研究,特别涉及雌马酚生产力和肠道细菌 NATTS。
- 批准号:
24659325 - 财政年份:2012
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Assessment of risk factors for ovarian cancer including serum equol concentration by histopathology with a case-control study
通过病例对照研究通过组织病理学评估卵巢癌的危险因素,包括血清雌马酚浓度
- 批准号:
22390135 - 财政年份:2010
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The study on risk factors for prostate cancer according to production of equol, a metabolite of isoflavone.
根据异黄酮代谢物雌马酚的产生来研究前列腺癌的危险因素。
- 批准号:
19390176 - 财政年份:2007
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life-style related risk factors for ovarian and endometrial cancer in a case-control study
病例对照研究中与生活方式相关的卵巢癌和子宫内膜癌危险因素
- 批准号:
16590505 - 财政年份:2004
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Cohort Study on the Association of Impaired Glucose Tolerance with Cancer Risk in 2 Towns of Hokkaido
北海道 2 个城镇葡萄糖耐量受损与癌症风险关联的队列研究
- 批准号:
12670366 - 财政年份:2000
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A follow-up study to assess prognostic factors for subjects with positive anti-HCV antibody.
一项评估抗 HCV 抗体阳性受试者预后因素的后续研究。
- 批准号:
08670437 - 财政年份:1996
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A CASE-CONTROL STUDY OF OVARIAN CANCER.SURVEY IN JAPAN FOR COMPARISON AMONG JAPANESE IN JAPAN,JAPANESE IN U.S.A., AND WHITE IN U.S.A.
日本卵巢癌调查的病例对照研究,以比较在日本的日本人、在美国的日本人和在美国的白人
- 批准号:
06670425 - 财政年份:1994
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Causal survival analysis with missing data in time-varying confounders
时变混杂因素中缺失数据的因果生存分析
- 批准号:
23K11017 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Statistical Inferences under Monotonic Hazard Trend in Survival Analysis
生存分析中单调危险趋势下的统计推断
- 批准号:
2311292 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Continuing Grant
CRII: III: Rethinking Fairness: Fairness as a Survival Analysis
CRII:III:重新思考公平:公平作为生存分析
- 批准号:
2245895 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Standard Grant
CRII:SCH: Interactive Explainable Deep Survival Analysis
CRII:SCH:交互式可解释深度生存分析
- 批准号:
2245739 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Standard Grant
CRII: III: Rethinking Fairness: Fairness as a Survival Analysis
CRII:III:重新思考公平:公平作为生存分析
- 批准号:
2404039 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Standard Grant
SCH: Interpretable survival analysis of complex longitudinal data
SCH:复杂纵向数据的可解释生存分析
- 批准号:
2306556 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Standard Grant
Copula-Based Methods for Multivariate Survival Analysis
基于 Copula 的多元生存分析方法
- 批准号:
2210481 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:
Standard Grant
Generalized linear mixed models for copula-based bivariate survival analysis
基于联结的二元生存分析的广义线性混合模型
- 批准号:
22K11948 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Spatial Variation in Insurance Policy Attrition: A Case Study in Spatial Survival Analysis
保单损耗的空间变异:空间生存分析的案例研究
- 批准号:
572951-2022 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:
University Undergraduate Student Research Awards
Efficient methods for genome-wide survival analysis of early childhood caries
儿童早期龋齿全基因组生存分析的有效方法
- 批准号:
10696112 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:














{{item.name}}会员




